BIO-Europe^® 2012 Press Releases

November 14, 2011BIO-Europe^® 2011 accelerates partnering in the life science industry Life science dealmakers from around the world engaged in thousands of partnering meetings and shared insights on strategies for building new and productive partnerships at BIO-Europe^® 2011, Europe's largest partnering conference, held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. "BIO-Europe was once again the defining partnering industry event...more ►

October 12, 2011BIO-Europe^® 2011 workshop to discover which biotech "has talent" Promising biotechs will have a unique opportunity to pitch their best assets to a star-studded panel of business development executives in a special competition at BIO-Europe^® 2011, being held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. In the workshop, "The Perfect Pitch: Biotech Has Talent," attendees will have a chance to win a one-to-one ...more ►

October 6, 2011BIO-Europe^® 2011 program to highlight non-traditional partnerships and the year's transformational deals Non-traditional healthcare alliances and the year's prominent transformational deals will be the topics of in-depth discussion in the opening and keynote plenary sessions at BIO-Europe^® 2011, being held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. In the opening plenary session, "Non-traditional Partnerships in the New Healthcare Ecosystem," mo...more ►

September 19, 2011World leaders in the life science industry to gather in Duesseldorf for the 17^th annual BIO-Europe^® partnering conference From October 31 to November 2, the world's life science leaders and dealmakers will gather in Duesseldorf, Germany for BIO-Europe^® 2011, Europe's largest partnering event serving the global biotechnology industry. Now in its seventeenth year, the three-day conference will host more than 3,000 attendees representing about 1,800 companies who will engage in more than 15,000 one-to-o...more ►

13 January 2012 Lights are flashing green for biotech investment in China While the rest of the world struggles, China is setting new records in venture capital investment, IPO and M&A activity, and partnering deals. more ►

13 January 2012 The exciting state of regenerative medicine Regenerative medicine has the power to transform healthcare, incorporating a wide variety of therapies. When incorporated into clinical practice, regenerative therapies may save USD 250 billion per year in the US alone. more ►

4 January 2012 Harry Glorikian: Opportunities in this market are abundant, but not obvious For many years Harry Glorikian, Managing Director, Scientia Advisors has been helping companies navigate the dynamic, yet increasingly turbulent, life science market. Over the holidays we had the chance to meet with Glorikian to get a peek at what’s in store for several sectors in the healthcare industry in 2012 and beyond. more ►

4 January 2012 Seegene: Multiplex assays key to companion diagnostics The quality of medical treatment is dependent on rapid and accurate diagnosing of the disease, as well as safeguarding the life of the patient. Apart from infectious diseases, most diseases do not have that "tell-all" diagnostic marker that provides an adequate picture of the patient and their particular disease. Seegene, Inc., sees a combination of surrogate markers in a single clinically validated assay as the most effective tool in disease identification, treatment and management, while keeping the patient in focus. more ►

4 January 2012 Anton Gueth: Troublesome financing environment to hit early stage companies hard in 2012 The excitement of the industry insiders is unfortunately not matched by those funding and regulating it. The challenges facing the industry are increasing every day. more ►